p53 and thymic 'death by neglect': Thymic epithelial cell-induced apoptosis of CD4+8+ thymocytes is p53-independent

Cell Death and Differentiation

Volumn 7, Issue 3, 2000, Pages 241-249

  Rosenheimer Goudsmid, N ^a   Haupt, Y ^a   Yefenof, E ^a   Zilberman, Y ^b   Guy, R ^a  

^a HEBREW UNIVERSITY   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Apoptosis; Death by neglect; Double positive thymocytes; p53; Thymic epithelial cells; Tumor suppresor protein

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; MUTANT PROTEIN; PROTEIN P53;

ANIMAL CELL; APOPTOSIS; ARTICLE; EPITHELIUM CELL; FEMALE; IONIZING RADIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; THYMOCYTE; THYMOMA;

ANIMALIA;

EID: 0034125553     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4400657     Document Type: Article

References (37)

1. Ashton-Rickardt PG, Bandeira A, Delaney JR, Van Kaer L, Pircher H-P, Zinkernagel RM and Tonegawa S (1994) Evidence for a differential avidity model of T cell selection in the thymus. Cell 76: 651-663
2. Amsen D and Kruisbeek AM (1998) Thymocyte selection: not by TcR alone. Immunol. Rev. 165: 209-229
3. Tolosa E and Ashwell JD (1999) Thymus-derived glucocorticoids and the regulation of antigen specific T cell development. Neuroimmunomodulation 6: 90-96
4. Gutierrez JC and Palacios R (1991) Heterogeneity of thymic epithelial cells in promoting T-lymphocyte differentiation in vivo. Proc. Natl. Acad. Sci. USA 88: 642-646
5. von Boehmer H and Kisielow P (1990) Self-nonself discrimination by T cells. Science 248: 1369-1373
6. Sprent J, Lo D, Gao EK and Ron Y (1988) T cell selection in the thymus. Immunol. Rev. 101: 173-190
7. Iwata M, Hanaoka S and Sato K (1991) Rescue of thymocytes and T cell hybridomas from GC-induced apoptosis by stimulation via the TcR/CD3 complex: a possible in vitro model for positive selection of the T cell repertoire. Eur. J. Immunol. 21: 643-648
8. Vacchio MS, Papadopoulus V and Ashwell JD (1994) Steroid production in the thymus: Implications for thymocyte selection. J. Exp. Med. 179: 1835-1846
9. Zacharchuk CM, Mercep M, Chakraborti PK, Simons JR SS and Ashwell JD (1990) Programmed T lymphocytes death. Cell activation and steroid-induced pathways are mutually antagonistic. J. Immunol. 145: 4037-4045
10. Zilberman Y, Yefenof E, Oron E, Dorogin A and Guy R (1996) T cell receptor-independent apoptosis of thymocyte clones induced by a thymic epithelial cell line is mediated by steroids. Cell. Immunol. 170: 78-84
11. Lowe SW, Schmitt EM, Smith SW, Osborne BA and Jacks T (1993b) p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362: 847-849
12. Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML and Wyllie AH (1993) Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362: 849-852
13. Halazonetis TD, Davis LJL and Kandil AN (1993) Wild-type p53 adopts a 'mutant'-like conformation when bound to DNA. EMBO J. 12: 1021-1028
14. Vogt Sionov R and Haupt Y (1998) Apoptosis by p53: mechanism, regulation, and clinical implications. Springer Semin. Immunopathol. 19: 345-362
15. Lotem J and Sachs L (1993) Hematopoietic cells from mice deficient in wild type p53 are more resistant to induction of apoptosis by some agents. Blood 82: 1092-1096
16. Levine AJ (1997) p53, the cellular gatekeeper for growth and division. Cell 88: 323-331
17. Donehower LA and Bradley A (1993) The tumor suppressor p53. Biochem. Biophys. Acta. 1155: 181-205
18. Jacks T, Remington L, Williams BO, Schmitt EM, Halachmi S, Bronson RT and Weinberg RA (1994) Tumor spectrum analysis in p53 mutant mice. Curr. Biol. 4: 1-7
19. Purdie CA, Harrison DJ, Peter A, Dobbie L, White S, Howie SE, Salter DM, Bird CC, Wyllie AH, Hooper ML and Clarke AR (1994) Tumor incidence, spectrum and ploidy in mice with a large deletion in the p53 gene. Oncogene 9: 603-609
20. + stage of thymocytes differentiation in the absence of TcR rearrangement. J. Exp. Med. 183: 1923-1928
21. Nacht M, Strasser A, Chan YR, Harris AW, Schlissel M, Bronson RT and Jacks T (1996) Mutations in the p53 and SCID genes cooperate in tumorigenesis. Genes Dev. 10: 2055-2066
22. Guy R, Gafnovitch I, Rosenheimer N, Oron E, Dorogin A, Yefenof E and Zilberman Y (1996) MHC non-restricted, CD95 independent apoptosis of immature thymocytes induced by thymic epithelial cells. Cell Death Differ. 3: 431-438
23. Zilberman Y, Katzav S, Yefenof E, Rosenheimer-Goudsmid N, Dorogin A and Guy R (1999) Apoptosis of thymic lymphoma clones by thymic epithelial cells: a putative model for 'death by neglect'. Immunol. Lett. 67: 95-104
24. Schreiber L, Sharabi Y, Schwartz D, Goldfinger N, Brodie C, Rotter V and Shoham J (1996) Induction of apoptosis and p53 expression in immature thymocytes by direct interaction with thymic epithelial cells. Scand. J. Immunol. 44: 314-322
25. Reinke V and Lozano G (1997) The p53 targets mdm2 and Fas are not required as mediators of apoptosis in vivo. Oncogene 15: 1527-1534
26. Nicolleti I, Migliorati G, Pagliacci MC, Grignani F and Riccardi C (1991) A rapid and simple method for measuring thymocytes apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods 139: 271-279
27. Strasser A, Harris AW, Jaks T and Cory S (1994) DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2. Cell 73: 329-339
28. Haupt Y, Rowan S, Shaulian E, Vousden KH and Oren M (1995) Induction of apoptosis in HeLa cells by trans-activation-deficient p53. Genes Dev. 9: 2170-2183
29. Yewdell JW, Gannon JV and Lane DP (1986) Monoclonal antibody analysis of p53 expression in normal and transformed cells. J. Virol. 59: 444-452
30. Ganon JV, Greaves R, Iggo R and Lane DP (1990) Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form. EMBO J. 9: 1595-1602
31. Hollstein M, Sidransky D, Vogelstein B and Harris CC (1991) p53 mutations in human cancers. Science 253: 49-53
32. Levine AJ, Momand J and Finlay CA (1991) The p53 tumor suppressor gene. Nature 351: 453-456
33. Li R, Sutphin PD, Schwartz D, Matas D, Almog N, Wolkowicz R, Goldfinger N, Pei H, Prokocimer M and Rotter V (1998) Mutant p53 protein expression interferes with p53-independent apoptotic pathways. Oncogene 16: 3269-3277
34. Aas T, Borresen A-L, Geisler S, Smith-Sorensen B, Johnsen H, Varhaug JE, Akslen LA and Lonning PE (1996) Specific p53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients. Nature Med. 2: 811-814
35. Blandino G, Levine AJ and Oren M (1999) Mutant p53 gain of function: differential effects of different p53 mutants on resistance of cultured cells to chemotherapy. Oncogene 18: 477-485
36. Ben-David Y, Yefenof E and Kotler M (1987) Clonal analysis of radiation leukemia virus-induced leukemic and preleukemic murine cells. Cancer Res. 47: 6590-6594
37. Glimcher LH, Kruisbeek AM, Paul WE and Green I (1983) Functional activity of a transformed thymic epithelial cell line. Scand. J. Immunol. 17: 1-11